Get the Stockscreener App
0.8398
2.79%
0.0228
Pre-market:
.79
-0.0498
-5.93%
Ispecimen Inc stock is traded at $0.8398, with a volume of 66,416.
It is up +2.79% in the last 24 hours and down -33.35% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$0.817
Open:
$0.802
24h Volume:
66,416
Relative Volume:
0.41
Market Cap:
$2.12M
Revenue:
$1.03M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.0127
EPS:
-66.0832
Net Cash Flow:
$-8.21M
1W Performance:
-12.51%
1M Performance:
-33.35%
6M Performance:
-82.94%
1Y Performance:
-97.48%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.7886
$0.9499
52-Week Range:
$0.7886
$36.32
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.8398 | 2.12M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Ispecimen Inc Stock (ISPC) Latest News
A 1-for-10 to 1-for-100 reverse split goes to iSpecimen (ISPC) voters October 30. - Stock Titan
iSpecimen approves AI deal as iSpecimen stock faces reverse split vote - ad-hoc-news.de
iSpecimen approves Foldlab AI deal with reverse split vote for iSpecimen stock - ad-hoc-news.de
iSpecimen Shareholders Approve Key Financing and Acquisition Actions - The Globe and Mail
More yes than no votes would approve iSpecimen (ISPC) reverse split on October 30. - Stock Titan
iSpecimen Shareholders Approve Key Financing and Acquisition Actions - TipRanks
A hospital is checking a new lab analyzer before clinical testing begins. - Stock Titan
iSpecimen Supports Hospital Validation of New Chemistry Analyzer - Yahoo Finance
Up to 80% discounts on future financings at iSpecimen (NASDAQ: ISPC) hinge on a shareholder vote. - Stock Titan
iSpecimen Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
iSpecimen Granted Nasdaq Extension to Regain Compliance - TipRanks
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
ISPC Stock Holds Ground As iSpecimen Delivers Cancer Research Milestone - timothysykes.com
ISPC Stock Draws Attention After Major Cancer Research Win - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ISPC Stock Draws Traders As Cancer Order Highlights Global Reach - timothysykes.com
ISPC Stock Draws Traders After Rapid Cancer Project Win - StocksToTrade
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - Benzinga
ISPECIMENDEAL VALUED AT $4.50 MLN: $2 MLN CASH, $2.50 MLN IN COMMON STOCKSEC FILING - Moomoo
iSpecimen to Acquire AI Assets from Foldlab AI for $4.5 Million - minichart.com.sg
iSpecimen to Acquire Foldlab AI Disease Analytics - TipRanks
iSpecimen (NASDAQ: ISPC) lines up reverse split and financings at up to an 80% discount - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4 - TradingView
iSpecimen to Acquire Foldlab AI Assets for $4.5 Million, Stock in 5-Year Escrow - TradingView
ISpecimenEnters Asset Purchase Agreement W - Moomoo
Five-year lock-up anchors iSpecimen (NASDAQ: ISPC) AI asset deal - Stock Titan
iSpecimen announces special shareholder meeting - Bitget
ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million. - marketscreener.com
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - vinanet.vn
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - siam.in
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBalance Sheet Strength - vinanet.vn
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBuyback Announcement Report - vinanet.vn
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Nigeria
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Canada
iSpecimen completes cancer research project in three weeks - Investing.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - The Manila Times
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com UK
iSpecimen Delivers Hundreds of International Cancer Blood Specimens Within Three Weeks, Highlighting Biospecimen Network Capabilities - kalkine.ca
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - vinanet.vn
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
An online marketplace sent hundreds of cancer samples abroad in three weeks - Stock Titan
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - Yahoo Finance
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordLong Term Entry Picks - vinanet.vn
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordContinuation Pattern Picks - siam.in
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordElliott Wave Count - dars.gov.et
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneCall Dominated - vinanet.vn
iSpecimen Inc. (ISPC) Slips 2.81% as Shares Test Key Technical LevelsPrice Momentum Stocks - dars.gov.et
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneTrend Continuation Trade - dars.gov.et
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.07%
13.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):